BJR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

British Journal of Radiology (2004) 77, 654-656
© 2004 British Institute of Radiology
doi: 10.1259/bjr/22832251

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Crawley, M T
Right arrow Articles by Oakley, F
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Crawley, M T
Right arrow Articles by Oakley, F

Full Paper

Patient and operator dose during fluoroscopic examination of swallow mechanism

M T Crawley, MSc, MIPEM1, P Savage, FRCS, FRCR1 and F Oakley, BSc, MRCSLT2

1 Radiology Department and 2 Speech and Language Therapy Department, Stoke Mandeville Hospital, Mandeville Road, Aylesbury, Buckinghamshire HP21 8AL, UK

Dose–area product (DAP) measurements were made for 21 patients undergoing a modified barium swallow. The procedures were performed by a radiologist and speech and language therapist, to characterize swallowing disorders in patients with head or spinal injury, stroke, other neurological conditions or simple globus symptoms, in order to inform feeding strategies. The DAP values were used to estimate effective dose to the patient, in order to provide a measure of the radiation risk associated with the procedure. Whole body doses to operators, together with equivalent doses to extremities and eyes were also measured to inform the employer's risk assessment. Median DAP for the series was 3.5 (3.1–5.2) Gycm2 with a corresponding effective dose to the patient of 0.85 (0.76–1.3) mSv, and a low associated risk, mainly of cancer induction, of about 1 in 16 000. The organ receiving the greatest dose was the thyroid, with a calculated median equivalent dose of 13.9 (12.3–20.7) mSv. Median screening time was 3.7 (2.5–4.3) min. Mean operator doses were 0.5 mSv equivalent dose (eyes), 0.9 mSv (extremities), and less than 0.3 mSv whole body dose. Extrapolating for an annual workload of 50 patients per year, this work will lead to annual operator doses of less than 0.6 mSv whole body dose, and approximately 1 mSv equivalent dose (eyes) and 1.8 mSv (extremities), against corresponding legal dose limits of 20 mSv, 150 mSv and 500 mSv, respectively.




This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
V. Panebianco, F. Francioni, M. Anzidei, M. Anile, M. Rolla, and R. Passariello
Magnetic resonance-fluoroscopy as long-term follow-up examination in patients with narrow gastric tube reconstruction after radical esophagectomy.
Eur. J. Cardiothorac. Surg., October 1, 2006; 30(4): 663 - 668.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
BJR DMFR IMAGING  ALL BIR JOURNALS 
Copyright © 2004 by the British Institute of Radiology.